Digital | Exploring pharma's evolving digital future

News

AI could spare bowel cancer patients from unneeded treatment

An AI tool could identify colorectal cancer patients most likely to respond to bevacizumab, which was recently backed for NHS use.

Digital

Trends outside the headlines, people reviewing graphs

Trends & Insights: February 2026 – A pharmaphorum industry r...

February's Trends Outside the Headlines, trends & insights report showed competitive advantage is increasingly shaped by delivery, not just discovery.

News

CT-155, and Boehringer Ingelheim and Click Therapeutics logos

Boehringer transfers schizophrenia DTx selling rights to Cli...

Boehringer has altered the terms of its digital therapeutic alliance with Click on schizophrenia app CT-155, taking a more strategic investor role.

News

AI giant Anthropic buys Coefficient Bio for $400m

Anthropic has continued its push into the healthcare sector by acquiring New York start-up Coefficient Bio.

Digital

Augmented intelligence: The next-gen engine for biopharma in...

Augmented intelligence is strategically valuable because it strengthens both the scientific and financial case for every decision.

News

PHTI review of digital hypertension tools gives mixed result...

An evaluation of digital health technologies for hypertension by the Peterson Health Technology Institute (PHTI) finds some provide a clinical benefit, while others are lacking.

News

Apple wins in Masimo lawsuit, but it's a shallow victory

The protracted legal wrangling between Apple and health wearable company Masimo has resulted in a nominal win for the tech giant – but failed to achieve its objectives.

Digital

Tech & Trials: Can AI save us from drowning in data?

Data – it’s everywhere! Especially in clinical trials, where an average trial of about 2,000 patients can expect to produce 3,000,000 points of data.

Debates

Spotlight on

Frontiers Health 2025

News

AI could spare bowel cancer patients from unneeded treatment

An AI tool could identify colorectal cancer patients most likely to respond to bevacizumab, which was recently backed for NHS use.

News

Boehringer transfers schizophrenia DTx selling rights to Cli...

Boehringer has altered the terms of its digital therapeutic alliance with Click on schizophrenia app CT-155, taking a more strategic investor role.

Press Releases

Partner Content

The PM Society Launches Pharmony to Support More Effective P...

The Pharmaceutical Marketing Society (PM Society) today announces the launch of Pharmony

Partner Content

EVERSANA Names Monica Avram Executive Vice President and Chi...

As chief legal officer and a member of the Executive Leadership Team, Monica Avram leads EVERSANA's global Legal and Compliance function.

Views & Analysis

Digital

Trends & Insights: February 2026 – A pharmaphorum industry r...

February's Trends Outside the Headlines, trends & insights report showed competitive advantage is increasingly shaped by delivery, not just discovery.

Digital

Augmented intelligence: The next-gen engine for biopharma in...

Augmented intelligence is strategically valuable because it strengthens both the scientific and financial case for every decision.

Digital

lady pointing at a number of data points

Sponsored

Solution Spotlight: Medscape AI

Medscape AI introduces a global, medical-grade AI search tool exclusively curated from the world’s largest body of clinically vetted content.

Deep Dive

Digital

Spatialomics and AI: A new age for personalised clinical med...

Digital

Reimagining the role of medical science liaisons in the age ...

Digital

The practical path to AI: Boosting field productivity in bio...

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Sponsored

Tracking studies get smarter: AI meets human intelligence

Having a continuous pulse on brand health is essential for pharmaceutical companies to inform strategic decisions and establish Key Performance Indicators (KPIs) in an ever-changing market

Digital

Linear visual illustration of nodes in an arrow shape

Sponsored

Enabling Digitally Enhanced Care for Rare Diseases in Europe

Integrating AI and Connected Care Technologies in Lysosomal Storage Disease Patient Journeys

Digital

Sponsored

The AI effect in pharma commercial strategy: From data to re...

Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.

Podcasts

Digital

BIO-Europe Spring podcast with Kashif Sadiq

Creating what nature has not from AI and computational molec...

Kashif Sadiq, founder and CEO of DenovAI Biotech discusses harnessing the power of artificial intelligence and computational molecular biophysics.

Digital

BIO-Europe Spring interview with Dr Olga Nissan

On collaboration, computational chemistry, and cutting-edge ...

Digital

pharmaphorum podcast Episode 242, Yann Gaston-Mathe, Iktos

JPM2026: Broadening AI drug discovery to include the lab, wi...

Yann Gaston-Mathe, founder and CEO of Iktos, discusses AI drug discovery's shift to real-world operations that are able to incorporate wet lab data.

Video

Digital

Sponsored

STEM AI: Delivering intelligent data-led HCP interactions

In a new sponsored video, pharmaphorum spoke with experts from STEM, an Inizio Ignite company, about STEM AI

Digital

Cracking the code: How European biotechs can win in the US m...

At Frontiers Health 2025, Mike Ryan, General Manager Europe at EVERSANA, tackled one of the most pressing questions for emerging pharma and biotech...

Digital

Balancing global consistency and local nuance: EVERSANA on A...

The conversation around global brand launches is evolving rapidly – and EVERSANA and its agency team at EVERSANA INTOUCH’s leadership is at the centre

White Papers

Digital

Sponsored

Expert Directed Applied Intelligence: Redefining AI in Life ...

In a new white paper from Lumanity, explore why the most powerful AI will always be human-directed.

Digital

White paper from Veeva on Clinical Data Industry Research

Sponsored

Data managers and CRAs warn of rising data quality risks due...

A new industry report uncovers the scope of a long-ignored problem in clinical trial operations.

Digital

Sponsored

Future proofing production: Implementing AI in pharmaceutica...

Read Zühlke’s new white paper, ‘Future Proof Production: Implementing AI in pharmaceutical manufacturing’ today.

Event

Partner Content

WOMA 2026: Steering the Future of Pharma Strategy

The WOMA Forum is not merely a conference. It's a convergence point for decision-makers

Event

Partner Content

Agentic AI is Ready. Most Pharma Organizations Are Not

Axtria Ignite 2026 returns June 10–11 in Princeton, New Jersey

Event

Book your tickets and join the PM Society for the 40th PM Aw...

Tickets are on sale for the 40th anniversary of the PM Awards

Digital

Sponsored

Digital natives: are pharma companies ready?

Health and life sciences companies face the challenging task of engaging key stakeholders

Views & Analysis

It’s time to tackle the gender health gap with technology

The potential for technology to transform the way we deliver healthcare is nothing new.

Webinars

Debiopharm-Webinar-Image-1200x675-Text-NEW2

Sponsored

The Digital Health Start-up Journey: Series A to scale-up

Although resources exist for digital health entrepreneurs looking to raise their first key investment round, industry advice on next steps is harder to find.

Partner Content

Event

Partner Content

WOMA 2026: Steering the Future of Pharma Strategy

The WOMA Forum is not merely a conference. It's a convergence point for decision-makers

Event

Partner Content

Agentic AI is Ready. Most Pharma Organizations Are Not

Axtria Ignite 2026 returns June 10–11 in Princeton, New Jersey

Press Releases

Partner Content

The PM Society Launches Pharmony to Support More Effective P...

The Pharmaceutical Marketing Society (PM Society) today announces the launch of Pharmony

Debates

News

Press Releases

Editor's Picks

Views & Analysis

Deep Dive

Webinars

Podcasts

Video

White Papers

Event

Debates & Insight

Partner Content

Editor's Picks